首页|血清LPS、LOXL2与阵发性心房颤动患者射频导管消融术后复发的相关性

血清LPS、LOXL2与阵发性心房颤动患者射频导管消融术后复发的相关性

Correlation of serum LPS,LOXL2 and recurrence after radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation

扫码查看
目的 探讨血清脂多糖(LPS)、赖氨酰氧化酶样蛋白 2(LOXL2)与阵发性心房颤动(PAF)患者射频导管消融(RFCA)术后复发的相关性.方法 选取 2020 年 5 月—2022 年 5 月在内蒙古自治区人民医院急诊心血管内科行RFCA术的PAF患者197 例(PAF组),同期医院体检健康者78 例(健康对照组).PAF组患者RFCA术后随访1 年,根据是否复发分为复发亚组63 例和未复发亚组134 例.采用酶联免疫吸附法检测血清LPS、LOXL2 水平;多因素Logistic回归分析PAF患者RFCA术后复发的因素,受试者工作特征(ROC)曲线分析血清LPS、LOXL2 水平对RFCA术后复发的预测价值.结果 与健康对照组比较,PAF组血清LPS、LOXL2 水平升高(Z =5.575、6.903,P均<0.001).197 例PAF患者 RFCA 术后 1 年复发率为 31.98%(63/197).与未复发亚组比较,复发亚组血清 LPS、LOXL2 水平升高(Z =6.431、6.543,P均<0.001).病程较长、左心房内径(LAD)增加、LPS升高、LOXL2 升高为PAF患者RFCA术后复发的独立危险因素[OR(95%CI)=2.335(1.450~3.761)、1.289(1.049~1.586)、1.025(1.014~1.035)、1.004(1.002~1.006)];血清LPS、LOXL2 及二者联合预测的AUC为 0.784、0.789、0.859,二者联合的AUC大于血清LPS、LOXL2 水平单独预测的AUC(Z/P =2.549/0.011、3.000/0.003).结论 PAF患者血清LPS、LOXL2水平升高,是PAF患者RFCA术后复发的独立危险因素,血清LPS、LOXL2 水平联合检测对PAF患者RFCA术后复发有较高的预测价值.
Objective To investigate the correlation between serum lipopolysaccharide(LPS),lysyl oxidase-like 2(LOXL2)and recurrence after radiofrequency catheter ablation(RFCA)in patients with paroxysmal atrial fibrillation(PAF).Methods One hundred and ninety-seven patients with PAF who underwent RFCA in the Department of Emergency Cardi-ovascular Medicine of the People's Hospital of the Inner Mongolia Autonomous Region from May 2020 to May 2022(the PAF group)and 78 physically examined healthy people in the same time period(the control group)were selected,and were divided into the recurrent subgroup(63 patients)and the non-recurrent subgroup(134 patients)according to whether or not they had relapsed at the one-year follow up.Serum LPS and LOXL2 levels were measured by enzyme-linked immunosorbent assay.The factors of postoperative recurrence of RFCA in PAF patients were analyzed by multifactorial Logistic regression,and the predictive value of serum LPS and LOXL2 levels for postoperative recurrence of RFCA was analyzed by ROC curve.Results Serum LPS and LOXL2 levels were elevated in the PAF group compared with the control group(Z=5.575,6.903,all P<0.001).The 1-year recurrence rate of RFCA in 197 PAF patients was 31.98%(63/197).Serum LPS and LOXL2 levels were elevated in the recurrent subgroup compared with the non-recurrent subgroup(Z=6.431,6.543,all P<0.001).Prolonged dis-ease duration,increased LAD,elevated LPS,and elevated LOXL2 were independent risk factors for recurrence after RFCA in patients with PAF[OR(95%CI)=2.335(1.450-3.761),1.289(1.049-1.586),1.025(1.014-1.035),1.004(1.002-1.006)].The AUCs predicted by serum LPS,LOXL2 and the combination of the two were 0.784,0.789,and 0.859,and the AUCs of the combination of the two were greater than the AUCs predicted by serum LPS and LOXL2 levels alone(Z=2.549,3.000,P= 0.011,0.003).Conclusion Elevated serum LPS and LOXL2 levels in patients with PAF are independent risk factors for re-currence after RFCA in patients with PAF,and the combination of serum LPS and LOXL2 levels has a high predictive value for recurrence after RFCA in patients with PAF.

Paroxysmal atrial fibrillationLipopolysaccharideLysyl oxidase-like protein 2Radiofrequency catheter ablationRecurrence

云冬晔、朱王亮、许志茹、孙欢、袁浩博

展开 >

010017 呼和浩特,内蒙古自治区人民医院急诊心血管内科

阵发性心房颤动 脂多糖 赖氨酰氧化酶样蛋白2 射频导管消融 复发

内蒙古自治区科技计划项目

2021GG0118

2024

疑难病杂志
中国医师协会

疑难病杂志

CSTPCD
影响因子:1.171
ISSN:1671-6450
年,卷(期):2024.23(5)
  • 27